The question that remains unresolved is succession.
One route is to treat the company as a candidate for a listing on Nasdaq or the New York Stock Exchange.
This is not a route for every company.
The question is not whether the asset is good. It is how to change the way it is held without destroying what makes it valuable.
Today, it sits on your balance sheet as a private asset with no public market price.
Your company has thirty years of audited history, recurring revenue, and a second-line management team that runs day-to-day operations.
On any objective measure, it is the kind of industrial asset institutional investors look for: predictable cash flows, working governance, and a clear balance sheet.
Sell to a rival, and everyone in the room knows what happens. The plant and the name do not survive in their current form. Production gets consolidated into the buyer’s footprint, and the company you built becomes a single line item inside someone else's accounts.
Sell to a private equity fund, and the operating substance stays, but the decision-making changes entirely. A new owner arrives with its own timetable, reporting cycle, and mandate measured in fund years.
Leaving the whole company to the next generation does not solve the problem either. They receive an indivisible asset that is difficult to value for tax purposes, hard to divide among heirs without friction, and difficult to finance against.
Doing nothing merely passes the issue down; it does not resolve it.
So when you treat the company as a possible candidate for a listing on Nasdaq or the New York Stock Exchange, the operating company does not change its name, its plant, or its team.
What changes is the form of the holding.
When listed as equity: shares that can be divided, transferred gradually, used as collateral, and sold down in small amounts over time at a price set by a market rather than by a single buyer.
Control can remain where it is. The mandate does not have to move to a rival or a fund. Only the ownership structure shifts.
This route works where three conditions are met, without which public markets will not buy the story.
First, scale: revenue north of €100M, profitability through cycles, and institutional-grade reporting.
Second, structure: audited accounts, functional board processes that do not rely on one individual at the center of every decision, and a management team that can stand in front of investors as a group.
Third, substance: a product, process, or market position that competitors cannot easily replicate.
If you looked at this option five or ten years ago and dismissed it, there were maybe good reasons at the time.
What has changed is that local exit windows have not reopened, while U.S. markets continue to capitalize mid-scale industrials that meet their standards.
One thing has not changed: a U.S. listing does not automatically deliver a higher valuation. The decision is about access to capital and turning an indivisible holding into divisible equity.